Opportunity overview
The provision of Prosigna tests used for breast cancer prognosis.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 12 Feb 2025
- Award ID
- 005190-2025-1
- Status
- active
- Identifier
- 00000N/A
- Location
- Frimley, UK, GU16 7UJ, United Kingdom
Classification
- CPV85100000 — Health services
Lots
- The provision of Prosigna tests used for breast cancer prognosis.<br/>Intending to award to an existing supplier provider following direct award process C <br/><br/>Value- £33,000Value not stated